Page 103 - Read Online
P. 103

Kozarov et al. Vessel Plus 2020;4:10  I  http://dx.doi.org/10.20517/2574-1209.2019.31                                                Page 17 of 18

               118.  Li L, Messas E, Batista EL Jr, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis
                   in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002;105:861-7.
               119.  Jain A, Batista EL Jr, Serhan C, Stahl GL, Van Dyke TE. Role for periodontitis in the progression of lipid deposition in an animal
                   model. Infect Immun 2003;71:6012-8.
               120.  Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, et al. Effects of infection and inflammation on lipid and lipoprotein
                   metabolism: mechanisms and consequences to the host. J Lipid Res 2004;45:1169-96.
               121.  Hardardóttir I, Grunfeld C, Feingold KR. Effects of endotoxin on lipid metabolism. Biochem Soc Trans 1995;23:1013-8.
               122. Pirillo A, Catapano AL, Norata GD. HDL in infectious diseases and sepsis. Handb Exp Pharmacol 2015;224:483-508.
               123.  Lassenius MI, Pietiläinen KH, Kaartinen K, Pussinen PJ, Syrjänen J, et al.; FinnDiane Study Group. Bacterial endotoxin activity in
                   human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 2011;34:1809-15.
               124.  Feingold KR, Grunfeld C. in Endotext KR, Feingold et al., Eds. MDText.com, Inc., South Dartmouth (MA); 2000. Available from
                   https://www.ncbi.nlm.nih.gov/books/NBK326741/ [Last accessed on 27 Feb 2020]
               125.  Grunfeld C, Marshall M, Shigenaga JK, Moser AH, Tobias P, et al. Lipoproteins inhibit macrophage activation by lipoteichoic acid. J
                   Lipid Res 1999;40:245-52.
               126.  Moretti E, Gonnelli S, Campagna M, Nuti R, Collodel G, et al. Influence of Helicobacter pylori infection on metabolic parameters and
                   body composition of dyslipidemic patients. Intern Emerg Med 2014;9:767-72.
               127.  Saxlin T, Suominen-Taipale L, Kattainen A, Marniemi J, Knuuttila M, et al. Association between serum lipid levels and periodontal
                   infection. J Clin Periodontol 2008;35:1040-7.
               128.  Korhonen S, Saxlin T, Suominen L, Jula A, Knuuttila M, et al. Serum cholesterol ratios and periodontal infection: results of the Health
                   2000 Survey. J Clin Periodontol 2011;38:787-94.
               129.  Nishimura F, Taniguchi A, Yamaguchi-Morimoto M, Soga Y, Iwamoto Y, et al. Periodontal infection and dyslipidemia in type 2
                   diabetics: association with increased HMG-CoA reductase expression. Horm Metab Res 2006;38:530-5.
               130.  Nepomuceno R, Pigossi SC, Finoti LS, Orrico SRP, Cirelli JA, et al. Serum lipid levels in patients with periodontal disease: a meta-
                   analysis and meta-regression. J Clin Periodontol 2017;44:1192-207.
               131.  Van Dyke TE. The management of inflammation in periodontal disease. J Periodontol 2008;79:1601-8.
               132.  Van Dyke TE, Kornman KS. Inflammation and factors that may regulate inflammatory response. J Periodontol 2008;79:1503-7.
               133.  Hasturk H, Kantarci A, Van Dyke TE. Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol
                   2012;15:160-76.
               134.  Grover V, Malhotra R, Kapoor A, Singh J, Sachdeva S. Proresolution mediators and receptors: novel drug targets for enhancing
                   pharmacological armamentarium against periodontal inflammation. Infect Disord Drug Targets 2013;13:75-84.
               135.  Hasturk H, Abdallah R, Kantarci A, Nguyen D, Giordano N, et al. Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in
                   diet and inflammation-induced atherogenesis. Arterioscler Thromb Vasc Biol 2015;35:1123-33.
               136.  Hamilton JA, Hasturk H, Kantarci A, Serhan CN, Van Dyke T. Atherosclerosis, periodontal disease, and treatment with resolvins.
                   Curr Atheroscler Rep 2017;19:57.
               137.  Elter JR, Hinderliter AL, Offenbacher S, Beck JD, Caughey M, et al. The effects of periodontal therapy on vascular endothelial
                   function: a pilot trial. Am Heart J 2006;151:47.
               138.  Shimada Y, Komatsu Y, Ikezawa-Suzuki I, Tai H, Sugita N, et al. The effect of periodontal treatment on serum leptin, interleukin-6,
                   and C-reactive protein. J Periodontol 2010;81:1118-23.
               139.  Desvarieux M, Demmer RT, Jacobs DR, Papapanou PN, Sacco RL, et al. Changes in clinical and microbiological periodontal profiles
                   relate to progression of carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology study. J Am Heart
                   Assoc 2013;2:e000254.
               140.  D’Aiuto F, Nibali L, Parkar M, Patel K, Suvan J, et al. Oxidative stress, systemic inflammation, and severe periodontitis. J Dent Res
                   2010;89:1241-6.
               141.  D’Aiuto F, Orlandi M, Gunsolley JC. Evidence that periodontal treatment improves biomarkers and CVD outcomes. J Clin Periodontol
                   2013;40:S85-105.
               142.  Inchingolo F, Marrelli M, Annibali S, Cristalli MP, Dipalma G, et al. Influence of endodontic treatment on systemic oxidative stress.
                   Int J Med Sci 2013;11:1-6.
               143.  Saffi MAL, Rabelo-Silva ER, Polanczyk CA, Furtado MV, Montenegro MM, et al. Periodontal therapy and endothelial function in
                   coronary artery disease: a randomized controlled trial. Oral Dis 2018;24:1349-57.
               144.  Wang Y, Andrukhov O, Rausch-Fan X. Oxidative stress and antioxidant system in periodontitis. Front Physiol 2017;8:910.
               145.  Scannapieco FA, Dasanayake AP, Chhun N. Does periodontal therapy reduce the risk for systemic diseases?. Dent Clin North Am
                   2010;54:163-81.
               146.  Falcao A, Bullón P. A review of the influence of periodontal treatment in systemic diseases. Periodontol 2000 2019;79:117-28.
               147.  Orlandi M, Suvan J, Petrie A, Donos N, Masi S, et al. Association between periodontal disease and its treatment, flow-mediated
                   dilatation and carotid intima-media thickness: a systematic review and meta-analysis. Atherosclerosis 2014;236:39-46.
               148.  Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, et al. Isolation of Chlamydia pneumoniae from a carotid endarterectomy
                   specimen. J Infect Dis 1997;176:292-5.
               149.  Kozarov E. Bacterial invasion of vascular cell types: vascular infectology and atherogenesis. Future Cardiol 2012;8:123-38.
               150.  Libby P. Fanning the flames: inflammation in cardiovascular diseases. Cardiovasc Res 2015;107:307-9.
               151.  Joensen JB, Juul S, Henneberg E, Thomsen G, Ostergaard L, et al. Can long-term antibiotic treatment prevent progression of
   98   99   100   101   102   103   104   105   106   107   108